Comment on "pP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"

Danilo Perrotti, Anupriya Agarwal, Claire M. Lucas, Goutham Narla, Paolo Neviani, Maria D. Odero, Peter P. Ruvolo, Nicole M. Verrills

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

LB100 does not sensitize CML stem cells to tyrosine kinase inhibitor-induced apoptosis.

Original languageEnglish (US)
Article numbereaau0416
JournalScience translational medicine
Volume11
Issue number501
DOIs
StatePublished - Jul 17 2019

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Comment on "pP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"'. Together they form a unique fingerprint.

Cite this